Medical UDI Laser Marking: From Data Content to Direct-Part Mark Verification

A medical UDI laser-marking acceptance test should show that the intended information reached the intended part, that the mark can be read and evaluated under defined conditions, and that the result belongs to a retrievable production record. A photograph of a dark code is not that complete evidence chain. Use the six gates below to turn a marking demonstration into an agreed equipment acceptance package.

For source selection, materials and station configuration, start with the medical UDI marking and traceability guide. This checklist focuses on what the buyer and supplier should exchange, test and sign off.

Freeze a marking contract before accepting samples

Create one controlled input pack: drawing revision, part identity, material and finish, approved data examples, permitted marking zone and the intended reading environment. Name the person responsible for approving each item. An equipment supplier should not have to infer the correct identifier or its permitted location from an unlabelled photograph.

Confirm the device-specific identification requirements separately. FDA's UDI framework covers more than the physical mark, and direct-marking provisions depend on the device and applicable rules. The device labeler should determine the applicable scope; the equipment project implements the agreed manufacturing task. FDA UDI Basics and its direct-marking guidance provide the starting references.

Use six acceptance gates, not one “code passed” field

These are separate decisions. A reader may return characters that do not match the approved order. A correctly encoded mark may still produce an unacceptable quality result under the agreed verification setup. Record both outcomes rather than allowing one green status to overwrite another.

For DPM, identify the exact assessment method rather than writing only “camera inspection.” ISO/IEC 29158:2025 addresses direct-part-mark symbol-quality testing, including measurement and reporting considerations. Specify the project's applicable parameters and criteria; neither a universally chosen grade nor a supplier screenshot defines acceptance for every medical component. See the official ISO scope and edition information.

Include a small, deliberate challenge set

Agree negative tests as part of the trial plan. Use controlled, clearly segregated test parts and test data—not identifiers intended for released production. The examples below are proposed test conditions, not reported AOGEO test results.

• Wrong data for the right part: present a controlled mismatch and verify that processing or release is stopped as specified.
• Unreadable or poorly positioned mark: confirm the no-read response and that manual intervention cannot silently convert it into a pass.
• Repeated identifier: check the agreed duplicate-detection scope, including what happens after a restart.
• Interrupted cycle or lost connection: establish the state of the physical part and whether a partial or missing record is recoverable.
• Rework request: demonstrate authorization, original-record retention and the rule for replacement or additional marks.

The useful question is not whether the station can display an alarm. It is whether the part, record and operator decision remain linked after the exception.

Make the report refer to the same physical part

Assign each trial sample an unambiguous local sample reference. Use it consistently in photographs, decoded-data checks, verification reports and any surface or lifecycle evaluation. A report from one sample cannot close an evidence gap on a different part merely because both used the same laser recipe.

A practical record manifest can list sample reference, drawing and data revisions, material/finish, recipe revision, processing result, inspection-report references, time and disposition. Agree which fields the station creates and which the customer's system supplies. For symbol verification, keep the relevant setup and verification-device status with the result. GS1's verification process guidance is a useful process reference; it does not replace the project specification.

Attach a defined evidence pack to the RFQ and FAT plan

1. Issue the controlled part, data and placement inputs, including permitted changes.
2. List the six gate owners and the required evidence for each sample or sampling group.
3. Define reader and verifier functions separately, including proposed interfaces.
4. Agree challenge tests, containment, rework and restart behavior.
5. Specify report format, file naming, record retrieval and who closes an unresolved item.

Review the medical UDI laser-marking and vision-traceability system against this pack. A configured station may include the laser, optics, fixture, vision, verification and data interfaces required by the project; confirm the supplied configuration rather than assuming every function is standard.

Before acceptance, reconcile the sample list against the evidence list and document any open conditions. Equipment acceptance supports a defined manufacturing workflow; it is not a declaration that every identification, device-validation or market obligation has been completed.

Explore the medical-device manufacturing application hub, or send the part drawing and marking acceptance requirements to plan a focused evaluation.

Technical references

• FDA: UDI Basics
• FDA: Unique Device Identification—Direct Marking of Devices
• ISO/IEC 29158:2025: scope and publication information
• GS1: Barcode Verification Process Implementation Guidelines